Table 1: Patient characteristics and preoperative data

Overall (n=232) Minor (n=211) Major (n=21) p
Age (years) 65 ± 9.73 65 ± 9.9 66 ± 8.7 0.749
Gender (M:F) 183:59 128 : 55 17 : 4 0,424
BMI 26 ± 3.85 26.5 ± 3.92 24.64 ± 3.87 0.117
MELD score 9 ± 1.67 8.66 ± 1.72 7.85 ± 0.90 0.009*
Preoperative INR 1.12 ± 0.83 1.13 ± 0.84 1.08 ± 0.55 0.035*
Preoperative PLT 166,698 ± 54,299 164,174 ± 53,241 203,384 ± 58,471 0.035*
N (%)
Cirrhosis 232 (100%) ns
Post-viral 197 (84.91%)
HBV 57 (24.57%) 52 (24.6%) 5 (23.8%)
HCV 128 (65.51%) 119 (56.4%) 9 (42.9%)
HBV + HCV 12 (5.17%) 9 (4.26%) 3 (14.3%)
Alcohol-related 17 (7.32%) 14 (6.63%) 3 (14.3%)
Criptogenetic 9 (3.87%) 9 (4.26%) 0
Dismetabolic 6 (2.58%) 5 (2.36%) 1 (4.7%)
Primary biliary cirrhosis 1 (0.43%) 1 (0.47%) 0
Hemochromatosis 2 (0.86%) 2 (0.95%) 0
Child-Pugh
A 227 (97.84%) 206 (97.6%) 21 (100%) ns
B 5 (2.15%) 5 (2.4%) 0
C 0 (0%) 0 0
 
BMI: Body Mass Index; MELD: Model of End Stage Liver Disease; PLT: Platelet; HBV: Hepatits B Virus; HCV: Hepatitis C Virus